Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Vasopressin and/or oxytocin receptor ligands described by Sanofi

June 18, 1997

Proischemic effect of enalapril in MI

June 17, 1997

Yamanouchi discloses new Na+/H+ exchange inhibitors

June 17, 1997

Gene Logic and P&G alliance for heart failure drug discovery

June 16, 1997

Highlights from the 12th Annual ASH Scientific Meeting

June 13, 1997

KW-3902 may be beneficial in hemorrhagic shock

June 13, 1997

Mylan files ANDA for generic nifedipine

June 12, 1997

Midodrine efficacy in diabetic patients with orthostatic hypotension

June 11, 1997

SR-BI receptor implicated in HDL metabolism

June 11, 1997

Eclipse cleared by FDA to begin clinical trials of PTMR

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...